|
COPYRIGHT 2003 International Medical News Group
MANCHESTER, ENGLAND -- Thalidomide remains an effective last-resort therapy for patients with severe cutaneous lupus, but even at low doses it can cause irreversible peripheral neuropathy, Dr. Maria J. Cuadrado said at the annual meeting of the British Society for Rheumatology.
This observation emerged from a study of 49 patients who had been unresponsive to hydroxychioroquine, mepacrine, prednisolone,...
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
